Inventor · disambiguated record
Amber Nicole Lee
Also filed as: LEE AMBER · LEE AMBER NICOLE
12 granted patents·12 pending applications·45 citations·filing 2019–2025
88Inventor score
Top patents by PatentIndex Score
24 records- 0196US11529587B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2020·Granted Dec 20, 2022·15 cites·29 claims
- 0295US11752468B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2022·Granted Sep 12, 2023·7 cites·25 claims
- 0395US11701388B2Thrombosomes as an antiplatelet agent reversal agentCELLPHIRE INC·Filed 2020·Granted Jul 18, 2023·10 cites·22 claims
- 0494US11813572B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2023·Granted Nov 14, 2023·5 cites·30 claims
- 0593US12208122B2Methods of treating bleeding in a subject treated with an antiplatelet agentCELLPHIRE INC·Filed 2024·Granted Jan 28, 2025·2 cites·30 claims
- 0692US11767511B2Platelets as delivery agentsCELLPHIRE INC·Filed 2019·Granted Sep 26, 2023·6 cites·22 claims
- 0783US12295972B2Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subjectCELLPHIRE INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 0879US12419914B2Thrombosomes as an antiplatelet agent reversal agentCELLPHIRE INC·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 0979US2025302880A1Platelet derivative compositions in the form of a powderCELLPHIRE INC·Filed 2025·Application pending·0 cites
- 1078US12378523B2Platelets as delivery agentsCELLPHIRE INC·Filed 2023·Granted Aug 5, 2025·0 cites·20 claims
- 1176US12370219B2Platelet derivative compositions, and pluralities of containers containing sameCELLPHIRE INC·Filed 2025·Granted Jul 29, 2025·0 cites·21 claims
- 1276US2023356150A1Materials and methods for producing blood productsCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 1373US12290532B2Treatment of von Willebrand diseaseCELLPHIRE INC·Filed 2024·Granted May 6, 2025·0 cites·20 claims
- 1473US2022273724A1Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 1565US2025115678A1T cell binding compositions and methodsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1664US2024066065A1Platelet derivatives for treating coagulopathyCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 1763US11903971B2Treatment of von Willebrand diseaseCELLPHIRE INC·Filed 2021·Granted Feb 20, 2024·0 cites·20 claims
- 1860US2023149467A1Platelet derivative compositions, and methods of making and using such compositionsCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 1957US2022279777A1Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 2056US2021180016A1PLATELETS LOADED WITH mRNACELLPHIRE INC·Filed 2020·Application pending·0 cites
- 2156US2022168353A1Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 2253US2021046120A1Thrombosomes as an anticoagulant reversal agentCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 2350US2021100846A1Use of platelets in treating infectionsCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 2447US2025177450A1Methods for administering freeze-dried platelet derivative compositions to subjects treated with a factor xi inhibitorCELLPHIRE INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →